Singapore-based Semiconductor Equipment and Materials Specialist Rokko Marks 30 Years of R&D Breakthroughs, Focus on Quality & Reliable Technical Support
SINGAPORE, Dec 13, 2022 – (ACN Newswire) – Rokko Holdings Ltd (“Rokko”) has marked its…
Year: 2022
Major Global Medical Device Manufacturer OrbusNeich Medical Group Announces Details of Proposed Listing on the Main Board of HKEX
HONG KONG, Dec 13, 2022 – (ACN Newswire) – OrbusNeich Medical Group Holdings Limited (“OrbusNeich”…
PETRONAS, Emerson to Collaborate on Digital Transformation and Decarbonization Initiatives
KUALA LUMPUR, Malaysia–(BUSINESS WIRE)–PETRONAS has recently inked a Memorandum of Understanding (MoU) with global technology…
Enterprise Financial Services Corp Announces Additions to Board of Directors
ST. LOUIS–(BUSINESS WIRE)–Enterprise Financial Services Corp (Nasdaq: EFSC) today announced the appointment of Lyne B….
Carina Biotech Submits an Investigational New Drug (IND) Application to US FDA for LGR5-Targeted CAR-T Cell Therapy Candidate
HIGHLIGHTS Files its first IND application for a CAR-T cell therapy targeting a solid cancer….
NGM Bio Gives Presentation Featuring Preclinical Characterization of NGM936 at 2022 ASH Annual Meeting
–NGM936, a ILT3 x CD3 bispecific T cell engager product candidate, potently induced T cell…
Tessa Therapeutics Announces Updated Safety, Efficacy and Biomarker Data from Phase 2 Trial of Autologous CD30.CAR-T Therapy (TT11) in Relapsed or Refractory Classical Hodgkin Lymphoma
Updated Results from CHARIOT Phase 2 trial presented at the 2022 ASH Annual Meeting indicate…
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
VANCOUVER, British Columbia, Dec. 12, 2022 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the…
89bio Announces Publication of Results of Phase 1b/2a Study of Pegozafermin for the Treatment of NASH in The Lancet Gastroenterology & Hepatology
– Data from cohorts 1-6 in the proof-of-concept study showed pegozafermin was generally well tolerated and had…
Pedro Resources Announces Changes to Board and Directors and Management
Toronto, Ontario–(Newsfile Corp. – December 12, 2022) – Pedro Resources Ltd. (CSE: VBN) (“Pedro” or…
CORRECTING and REPLACING Amidst the Bear Market, New Math Startup Nillion Assembles ‘Avengers Team’ and Raises $20m+ From Over 150 Strategic Contributors Without a Deck
Investors bet on new internet infrastructure that the Founding Team of Uber, Indiegogo and Hedera…
Metropolitan Launches Dashboard to Track Progress on Greenhouse Gas Emission Reductions
Web-based CAPDash portal increases data transparency as Metropolitan implements Climate Action Plan LOS ANGELES–(BUSINESS WIRE)–As…
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Singularity Future Technology Ltd. f/k/a Sino-Global Shipping America Ltd. (SGLY) Investors
BENSALEM, Pa.–(BUSINESS WIRE)–Law Offices of Howard G. Smith announces that a class action lawsuit has…
Frost & Sullivan Names Vonage Asia-Pacific Communications Platform as a Service (CPaaS) Company of the Year for Fourth Consecutive Year
HOLMDEL, N.J.–(BUSINESS WIRE)–Vonage, a global business cloud communications leader helping businesses accelerate their digital transformation,…
Jack in the Box Inc. Announces Departure of CFO Tim Mullany
SAN DIEGO–(BUSINESS WIRE)–Jack in the Box Inc. (NASDAQ: JACK) announced today that Tim Mullany, Executive…
Aimco Urges Stockholders to Support Its Three Highly Qualified Director Nominees – Jay Leupp, Michael Stein and Dary Stone
Files Investor Presentation Highlighting Highly Qualified Director Nominees, Successful Track Record and Corporate Governance Enhancements…
Nurix Therapeutics Presents Positive Clinical Results from its Novel BTK Degrader (NX-2127) at the 64th American Society of Hematology (ASH) Annual Meeting
Treatment with NX-2127 provides clinically meaningful responses in heavily pretreated chronic lymphocytic leukemia (CLL) patients…
Enzo Biochem Reports First Quarter Fiscal Year 2023 Financial Results and Provides Business Update
– Enzo Life Sciences reports revenue of $7.1 million and 9% growth in Q1 FY…
Magenta Therapeutics Presents Positive MGTA-117 Clinical Data at the American Society of Hematology (ASH) Annual Meeting and Provides Program Updates
– MGTA-117 preliminary clinical results from 15 patients across three dose-escalation cohorts of the ongoing…
Quotient Limited Announces Intent to Voluntary Delist from the Nasdaq Global Market
JERSEY, Channel Islands, Dec. 12, 2022 (GLOBE NEWSWIRE) — Quotient Limited (Nasdaq: QTNT) (the “Company”)…